These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1910082)

  • 21. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
    Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
    Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once daily.
    Cooley TP; Kunches LM; Saunders CA; Perkins CJ; Kelley SL; McLaren C; McCaffrey RP; Liebman HA
    Rev Infect Dis; 1990; 12 Suppl 5():S552-60. PubMed ID: 1974727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).
    Jackson GG; Paul DA; Falk LA; Rubenis M; Despotes JC; Mack D; Knigge M; Emeson EE
    Ann Intern Med; 1988 Feb; 108(2):175-80. PubMed ID: 3124680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex.
    Dolin R; Lambert JS; Morse GD; Reichman RC; Plank CS; Reid J; Knupp C; McLaren C; Pettinelli C
    Rev Infect Dis; 1990; 12 Suppl 5():S540-9; discussion S549-51. PubMed ID: 1974726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients.
    Rinaldo C; Huang XL; Piazza P; Armstrong J; Rappocciolo G; Pazin G; McMahon D; Gupta P; Fan Z; Zhang Z
    J Infect Dis; 1991 Oct; 164(4):638-45. PubMed ID: 1680135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction.
    Mermin JH; Holodniy M; Katzenstein DA; Merigan TC
    J Infect Dis; 1991 Oct; 164(4):769-72. PubMed ID: 1680138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine.
    Jacobson MA; Abrams DI; Volberding PA; Bacchetti P; Wilber J; Chaisson RE; Crowe S; Howard W; Moss A
    J Infect Dis; 1989 Jun; 159(6):1029-36. PubMed ID: 2566637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
    Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considerations in the selection of end points for AIDS clinical trials.
    Amato DA; Lagakos SW
    J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 2():S64-8. PubMed ID: 2121954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of 2',3'-dideoxyinosine: experience with 19 patients at New York University Medical Center.
    Valentine FT; Seidlin M; Hochster H; Laverty M
    Rev Infect Dis; 1990; 12 Suppl 5():S534-9. PubMed ID: 1974725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of infectious immune complexes in human immunodeficiency virus type 1 (HIV-1) infections: correlation with plasma viremia and CD4 cell counts.
    Fiscus SA; Wallmark EB; Folds JD; Fryer J; van der Horst CM
    J Infect Dis; 1991 Oct; 164(4):765-9. PubMed ID: 1680137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prediction of the clinical course of AIDS in a cohort of 77 seropositive persons. Importance of p24 antigen in the blood and the level of serum IgA].
    Salmon D; Lambin P; Couroucé AM; Lefrère JJ; Doinel C; Rouger P; Salmon C
    Rev Fr Transfus Hemobiol; 1990 Jan; 33(1):21-9. PubMed ID: 1971171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles.
    Yarchoan R; Mitsuya H; Pluda JM; Marczyk KS; Thomas RV; Hartman NR; Brouwers P; Perno CF; Allain JP; Johns DG
    Rev Infect Dis; 1990; 12 Suppl 5():S522-33. PubMed ID: 1974724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects.
    Mulder JW; Lange JM; de Wolf F; Houweling JT; Bakker M; Coutinho RA; Goudsmit J
    Neth J Med; 1990 Aug; 37(1-2):4-10. PubMed ID: 2120599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone reduces levels of AIDS virus in blood.
    Oncology (Williston Park); 1989 Oct; 3(10):19. PubMed ID: 2518005
    [No Abstract]   [Full Text] [Related]  

  • 36. Zidovudine treatment of AIDS and ARC in Denmark 1987.
    Teglbjaerg LL; Mathiesen LR; Søeberg B; Nielsen L; Thorsen B; Buhl M; Pedersen C; Bonnevie O; Nielsen C; Vestergaard BF
    Scand J Infect Dis; 1989; 21(4):367-73. PubMed ID: 2685984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the progression to AIDS.
    Polis MA; Masur H
    Am J Med; 1990 Dec; 89(6):701-5. PubMed ID: 1979204
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.
    Mulder JW; Krijnen P; Coutinho RA; Bakker M; Goudsmit J; Lange JM
    Genitourin Med; 1991 Jun; 67(3):188-93. PubMed ID: 1906425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.
    McKinney RE; Maha MA; Connor EM; Feinberg J; Scott GB; Wulfsohn M; McIntosh K; Borkowsky W; Modlin JF; Weintrub P
    N Engl J Med; 1991 Apr; 324(15):1018-25. PubMed ID: 1672443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of azidothymidine (AZT) on HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS.
    Reddy MM; McKinley G; Englard A; Grieco MH
    Int J Immunopharmacol; 1990; 12(7):737-41. PubMed ID: 2127261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.